Introduction: Dyslipidemia, characterized by abnormal lipid levels in the blood, represents a significant risk factor for cardiovascular disease (CVD), the leading cause of morbidity and mortality worldwide. The dyslipidemia treatment market encompasses a wide array of therapeutic interventions aimed at reducing lipid levels, preventing CVD events, and improving patient outcomes. With the increasing prevalence of […]
Tag: Dyslipidemia Treatment Market
Back To Top